Monitor
Quote
Charts
Trades
News
Financials
Toplists
Alerts
Portfolio
Level 2
Free BB
PBB
28/08/2008
21:55:37
Site map
<a href="http://as1.advfn.com/oasis/oasisc.php?s=536&w=468&h=60&ord=1219956937&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=536&w=468&h=60&ord=1219956937&t=_blank" border='0' width='468' height='60'></a>
Help
<a href="http://as1.advfn.com/oasis/oasisc.php?s=2218&w=120&h=30&ord=1219956937&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=2218&w=120&h=30&ord=1219956937&t=_blank" border='0' width='120' height='30'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=2730&w=120&h=30&ord=1219956937&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=2730&w=120&h=30&ord=1219956937&t=_blank" border='0' width='120' height='30'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=879&w=120&h=30&ord=1219956937&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=879&w=120&h=30&ord=1219956937&t=_blank" border='0' width='120' height='30'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=3376&w=120&h=30&ord=1219956937&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=3376&w=120&h=30&ord=1219956937&t=_blank" border='0' width='120' height='30'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=2188&w=120&h=30&ord=1219956937&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=2188&w=120&h=30&ord=1219956937&t=_blank" border='0' width='120' height='30'></a>
Combimatrix News
(NASDAQ:CBMX)
Combimatrix stock quote
|
Combimatrix company information
|
Combimatrix Stock Chart
Latest Combimatrix News Headlines
Date
Time
Source
Headline
18/08/2008
20:26
PRNUS
Emerging Growth Equities, Ltd. Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an $18.00 Price Target
KING OF PRUSSIA, Pa., Aug. 18 /PRNewswire/ -- Emerging Growth Equities, Ltd. initiates coverage of CombiMatrix Corporation (NASDAQ:CBMX) with a BUY rating and an $18.00 price target. CombiMatrix is a life sciences company focused on developing and commercializing in vitro genetic diagnostics that leverage its core...
More...>>
31/01/2008
11:00
PRNUS
CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)
The HemeScan(TM) Test Provides Prognostic Marker Precision and Simultaneous Diagnostic Monitoring MUKILTEO, Wash. and ALISO VIEJO, Calif., Jan. 31 /PRNewswire-FirstCall/ -- CombiMatrix Corporation (NASDAQ:CBMX) and Clarient, Inc. (NASDAQ:CLRT) today jointly announced establishment of a strategic partnership to market...
More...>>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=2216&w=120&h=600&ord=1219956937&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=2216&w=120&h=600&ord=1219956937&t=_blank" border='0' width='120' height='600'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=2397&w=728&h=90&ord=1219956937&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=2397&w=728&h=90&ord=1219956937&t=_blank" border='0' width='728' height='90'></a>
LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's
Terms & Conditions
::
Contact Us
::
Request an Exchange
::
Affiliate Scheme
Copyright1999-2008 ADVFN PLC.
Copyright and limited reproduction
::
Privacy Policy
::
Investment Warning
::
Advertise with us
::
Data accreditations
:: ::
Press office
::
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
32 site:2gb nasdaq cbmx080828 21:55